Gilead Sciences pharmaceutical business is seen in Oceanside, California, on April 29, 2020 after they revealed a Stage 3 Trial of the investigational antiviral drug remdesivir in patients with serious coronavirus disease (COVID-19).|Photo Credit:
REUTERS.
.
.
Drug has nod for emergency situation use
Remdesivir shows ‘precise’ effect in treating COVID-19
They sign up with Hetero Labs, Jubilant Lifesciences and Mylan, who had actually signed the arrangement last month with Gilead.
An investigational antiviral treatment, remdesivir has receiv